Dietary chemopreventive compounds and ARE/EpRE signaling
1Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Abstract:
Chemoprevention comprises multiple intervention methods using either pharmacological or dietary agents to impede, arrest, or reverse carcinogenesis at various stages. Development of dietary compounds as potential cancer chemopreventive agents is highly desirable, due to their safety, low toxicity, and general acceptance as dietary supplements. In this review, potential application of the dietary detoxifying enzyme inducers for chemoprevention and their relevant signaling events are discussed. Overall, the detoxifying enzyme system plays an important role in determining the final fate of carcinogens/procarcinogens and their subsequent impact on carcinogenesis. Among those positive regulators, phenolic and sulfur-containing compounds are two major classes of dietary detoxifying enzyme inducers. Regulation of many detoxifying enzymes by dietary chemopreventive compounds is mediated by the antioxidant response element (ARE)/electrophile response element (EpRE), which is located in the promoter region of related genes. Transcription factor nuclear factor E2-related factor 2 (Nrf2) binds to the ARE sequence to initiate gene expression. In response to treatments of various detoxifying enzyme inducers, several signal transduction pathways, including the oxidative stress, mitogen-active protein kinase, protein kinase C, and phosphatidylinositol 3-kinase pathways, are activated. The consequences of the activation of these signaling cascades, whether directly or indirectly, lead to the dissociation of Nrf2 from its cytosolic sequester Kelch-like ECH associating protein 1, nuclear translocation, and accumulation of Nrf2 protein in the nucleus, and ultimately increase the expression level of detoxifying enzymes through transcriptional activation of ARE/EpRE in those responsible genes.
Insights
Dietary compounds like phenolic and sulfur-rich agents can induce detoxifying enzymes, offering a safe approach to cancer chemoprevention. These compounds activate the Nrf2 pathway, increasing the expression of protective enzymes against carcinogens.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Chemoprevention utilizes agents to prevent or reverse cancer development.
- Dietary compounds are attractive for chemoprevention due to safety and acceptance.
- Detoxifying enzymes play a crucial role in processing carcinogens.
Purpose of the Study:
- To review the application of dietary detoxifying enzyme inducers in cancer chemoprevention.
- To discuss the signaling events involved in this process.
- To highlight the role of phenolic and sulfur-containing compounds.
Main Methods:
- Review of scientific literature on chemoprevention and enzyme induction.
- Analysis of signaling pathways regulating detoxifying enzymes.
- Focus on the antioxidant response element (ARE)/electrophile response element (EpRE) and Nrf2 pathway.
Main Results:
- Dietary compounds, particularly phenolic and sulfur-containing ones, induce detoxifying enzymes.
- Regulation is mediated by the ARE/EpRE sequence and transcription factor Nrf2.
- Activation of signaling pathways (oxidative stress, MAPK, PKC, PI3K) leads to Nrf2 nuclear translocation.
Conclusions:
- Dietary detoxifying enzyme inducers are promising for cancer chemoprevention.
- The Nrf2-ARE/EpRE pathway is central to their mechanism.
- Understanding these signaling events can lead to novel chemopreventive strategies.
Related Concept Videos
Cancer Prevention
Some...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Mutagenicity and Carcinogenicity
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
